Development Level

Tbio 4 | 10,625
Tchem 2 | 1,890

IMPC Term

decreased mature B cell number 1 | 25
increased circulating calcium ... 1 | 32
increased leukocyte cell numbe... 1 | 37
preweaning lethality, complete... 1 | 633

Disease

psoriasis 5 | 6,685
Cancer 4 | 2,346
glioblastoma 4 | 5,572
medulloblastoma, large-cell 4 | 6,234
osteosarcoma 4 | 7,933
Pick disease 3 | 1,893
malignant mesothelioma 3 | 3,163
ovarian cancer 3 | 8,492
HIV Infections 2 | 100
Intellectual disability 2 | 573
Mammary Neoplasms 2 | 410
Neoplasm Metastasis 2 | 138
astrocytic glioma 2 | 2,241
atypical teratoid / rhabdoid tumor 2 | 4,369
ependymoma 2 | 2,514
gastric cancer 2 | 436
group 4 medulloblastoma 2 | 1,875
hepatocellular carcinoma 2 | 550
intraductal papillary-mucinous carcinoma (IPMC) 2 | 2,988
intraductal papillary-mucinous neoplasm (IPMN) 2 | 3,289
lung cancer 2 | 4,473
oligodendroglioma 2 | 2,849
pediatric high grade glioma 2 | 2,712
pilocytic astrocytoma 2 | 3,086
subependymal giant cell astrocytoma 2 | 2,287
Aarskog-Scott syndrome 1 | 11
Adams-Oliver syndrome 1 | 13
Adenocarcinoma 1 | 115
Adrenal Gland Neoplasms 1 | 11
Age related macular degeneration 1 | 84
Animal Mammary Neoplasms 1 | 136
Autistic Disorder 1 | 320
Blindness 1 | 84
Breast cancer 1 | 3,099
COPD 1 | 116
Cadasil 1 | 10
Carcinoma 1 | 2,147
Chromoblastomycosis 1 | 8
Cleft palate 1 | 125
Clostridium difficile colitis 1 | 12
Cone dystrophy 1 | 59
Congenital stationary night blindness 1 | 28
Diabetic Retinopathy 1 | 53
Disease Progression 1 | 125
Endometriosis 1 | 535
Eye disease 1 | 55
Fundus dystrophy 1 | 77
Gastric ulcer 1 | 34
Gastrointestinal system disease 1 | 50
Hypomagnesemia 4 1 | 1
Hypomagnesemia 4, Renal 1 | 1
Juvenile arthritis 1 | 124
Keloid 1 | 34
Keratomalacia 1 | 6
Kidney Diseases 1 | 86
Kidney disease 1 | 397
Leber congenital amaurosis 1 | 72
Liver carcinoma 1 | 217
Mammary Neoplasms, Experimental 1 | 150
Metaplasia 1 | 3
Multiple myeloma 1 | 1,328
NEPHROTIC SYNDROME, TYPE 8 1 | 1
Necrosis 1 | 51
Neoplasm Invasiveness 1 | 127
Neoplastic Cell Transformation 1 | 81
Nephrotic syndrome 8 1 | 1
Night Blindness 1 | 39
Night blindness, congenital stationary 1 | 14
Peripheral Neuropathy 1 | 303
Polycystic Ovary Syndrome 1 | 335
Polycystic kidney disease 1 | 54
Precancerous Conditions 1 | 69
Prostatic Neoplasms 1 | 471
Pulmonary Fibrosis 1 | 66
Reperfusion Injury 1 | 84
Retinal Degeneration 1 | 49
Retinal detachment 1 | 33
Retinitis 1 | 9
Retinitis pigmentosa 1 | 156
Schizophrenia 1 | 503
Uveitis 1 | 103
Vascular disease 1 | 281
Wiskott-Aldrich syndrome 1 | 27
acute myeloid leukemia 1 | 785
adult high grade glioma 1 | 2,148
astrocytoma 1 | 1,493
breast carcinoma 1 | 1,614
cone-rod dystrophy 1 | 60
diabetes mellitus 1 | 1,663
intraductal papillary-mucinous adenoma (IPMA) 1 | 2,956
lung adenocarcinoma 1 | 2,714
medulloblastoma 1 | 1,524
non diabetic and post-ischemic heart failure 1 | 200
pancreatic cancer 1 | 2,300
pancreatic carcinoma 1 | 567
posterior fossa group A ependymoma 1 | 1,511
primary pancreatic ductal adenocarcinoma 1 | 1,271
progressive supranuclear palsy 1 | 674
renal hypomagnesemia 4 1 | 1
tuberculosis 1 | 1,563

Tissue

Blood and immune system 6 | 17,995
Cardiovascular System 6 | 17,958
Digestive Tract 6 | 18,473
Endocrine System 6 | 18,512
Female tissues 6 | 18,647
Liver and Pancreas 6 | 18,136
Male tissues 6 | 17,969
Nervous System 6 | 18,561
Respiratory system 6 | 17,484
Skin and soft tissues 6 | 18,115
Urinary Tract 6 | 18,444

Target Family

Non-IDG 3 | 11,969
Enzyme 2 | 4,146
GPCR 1 | 408

Grant Application

2R01GM047458-13 6 | 6
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Ras-related protein Ral-B RALB Tbio Enzyme -1.70223 49.7 204
Rho GDP-dissociation inhibitor 1 ARHGDIA Tchem Non-IDG -2.55630 360.5 330
Pro-epidermal growth factor EGF Tbio Non-IDG -3.74596 4837.7 851
Rhodopsin RHO Tbio GPCR -3.78489 6671.2 350
Cell division control protein 42 homolog CDC42 Tchem Enzyme -3.35070 2084.6 341
Rho guanine nucleotide exchange factor 7 ARHGEF7 Tbio Non-IDG -2.13575 139.1 160